Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers T > Headlines for Theravance Inc. > News item |
Theravance files $200 million shelf registering debt, stock, warrants
By Devika Patel
Knoxville, Tenn., July 23 - Theravance Inc. filed a $200 million shelf registration in an S-3 filing with the Securities and Exchange Commission.
The registration covers common stock, debt securities and warrants.
The securities may be structured as convertibles.
Proceeds will be used for general corporate purposes.
Theravance is a South San Francisco, Calif.-based biopharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.